Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07416786 · ClinicalTrials.gov registry record · NA
Validation of NAD+ Measurements for Human Clinical Studies
A NA study, sponsored by University of Pennsylvania.
- Not yet
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT07416786: Clinical Trial NA study, sponsored by University of Pennsylvania.
NCT07416786 is a NA study that has not yet begun recruiting, run by University of Pennsylvania. The registered enrollment target is 48 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07416786, a NA study, has not yet begun recruiting, sponsored by University of Pennsylvania.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of this study is to determine nicotinamide adenine dinucleotide (NAD) levels in healthy adult subjects before and after supplementing with over-the counter nicotinamide riboside (NR) using magnetic resonance spectroscopy (MRS).
Interventions
- DIETARY_SUPPLEMENT Oral NR Supplementation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2028-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07416786
The ClinicalTrials.gov registry entry for NCT07416786 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oral NR Supplementation is the first listed.
NCT07416786 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07416786 about?
NCT07416786 is a clinical study titled "Validation of NAD+ Measurements for Human Clinical Studies". The purpose of this study is to determine nicotinamide adenine dinucleotide (NAD) levels in healthy adult subjects before and after supplementing with over-the counter nicotinamide riboside (NR) using magnetic resonance spectroscopy (MRS).
What is the current status of trial NCT07416786?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2026-07-01. Estimated completion is 2028-07-31.
What interventions are being tested in trial NCT07416786?
The interventions under investigation include: Oral NR Supplementation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07416786?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.